Literature DB >> 32877543

Opioid Use and Chronic Infections: The Value of Addressing the Syndemic in Correctional Settings Via Telemedicine Guidance and Broader Use of Long-Acting Medications.

Martin Krsak1, Brian T Montague1, Paul Trowbridge2, Steven C Johnson1, Ingrid A Binswanger3,4,5.   

Abstract

In the United States, we are experiencing linked epidemics (a syndemic) of substance use disorders (SUDs) and infections associated with drug use, including unsafe injecting and unsafe sex in exchange for drugs or money. Current drug laws, together with risk-taking behavior among persons with SUDs, contribute to disproportionately high prevalences of these conditions in correctional settings. Detection and treatment of diseases with a high impact on public health are best addressed in the settings where such conditions are most prevalent (ie, jails and prisons for SUDs and chronic infections). The effectiveness, safety, cost of care. and public health impact of these conditions can be improved by means of broader screening and expanded access to specialty consultations through telemedicine/telehealth, along with broader use of long-acting medications for the treatment of human immunodeficiency virus and SUDs. Expanding telemedicine/telehealth, first for specialties which do not require advanced technology (eg, infectious diseases, addictions), can eventually lead to further advancements in correctional healthcare.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HCV; HIV; Substance use; correctional healthcare; jails; long-acting medications; opioid use; prisons; telehealth; telemedicine

Mesh:

Substances:

Year:  2020        PMID: 32877543     DOI: 10.1093/infdis/jiaa001

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  2 in total

1.  Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study.

Authors:  Cayley Russell; Frishta Nafeh; Michelle Pang; Shanna Farrell MacDonald; Dena Derkzen; Jürgen Rehm; Benedikt Fischer
Journal:  BMC Public Health       Date:  2022-03-04       Impact factor: 3.295

2.  Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada.

Authors:  Cayley Russell; Michelle Pang; Frishta Nafeh; Shanna Farrell Macdonald; Dena Derkzen; Jürgen Rehm; Benedikt Fischer
Journal:  Int J Qual Stud Health Well-being       Date:  2022-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.